Mitral stenosis screening: Difference between revisions
| Line 5: | Line 5: | ||
==Overview== | ==Overview== | ||
According to the 2014 and 2017 AHA/ACC Guideline, screening for mitral stenosis by TTE is recommended | According to the 2014 and 2017 AHA/ACC [[Medical guideline|Guideline]], screening for mitral stenosis by [[TTE]] is recommended among [[patients]] with [[Medical sign|signs]] or [[Symptom|symptoms]]. " [[Exercise stress testing|Exercise testing]] with [[Doppler]] or [[Invasive (medical)|invasive]] [[Hemodynamic assessment in the cardiac catheterization laboratory|hemodynamic assessment]] is recommended to evaluate the response of the mean [[Mitral valve|mitral]] [[gradient]] and [[pulmonary]] [[artery]] [[pressure]] in [[Patient|patients]] with MS when there is a discrepancy between resting [[Doppler]] [[echocardiographic]] findings and [[clinical]] [[Symptom|symptoms]] or [[Medical sign|signs]]". | ||
==Screening== | ==Screening== | ||
Exercise testing with Doppler or invasive hemodynamic assessment is recommended to evaluate the response of the mean mitral gradient and pulmonary artery pressure in patients with MS when there is a discrepancy between resting Doppler echocardiographic findings and clinical symptoms | According to the 2014 and 2017 AHA/ACC [[Medical guideline|Guideline]], screening for mitral stenosis by [[TTE]] is recommended among [[patients]] with [[Medical sign|signs]] or [[Symptom|symptoms]]. " [[Exercise stress testing|Exercise testing]] with [[Doppler]] or [[Invasive (medical)|invasive]] [[Hemodynamic assessment in the cardiac catheterization laboratory|hemodynamic assessment]] is recommended to evaluate the response of the mean [[Mitral valve|mitral]] [[gradient]] and [[pulmonary]] [[artery]] [[pressure]] in [[Patient|patients]] with MS when there is a discrepancy between resting [[Doppler]] [[echocardiographic]] findings and [[clinical]] [[Symptom|symptoms]] or [[Medical sign|signs]]". | ||
==References== | ==References== | ||
Revision as of 20:14, 10 March 2020
|
Mitral Stenosis Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Mitral stenosis screening On the Web |
|
American Roentgen Ray Society Images of Mitral stenosis screening |
|
Risk calculators and risk factors for Mitral stenosis screening |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:
Overview
According to the 2014 and 2017 AHA/ACC Guideline, screening for mitral stenosis by TTE is recommended among patients with signs or symptoms. " Exercise testing with Doppler or invasive hemodynamic assessment is recommended to evaluate the response of the mean mitral gradient and pulmonary artery pressure in patients with MS when there is a discrepancy between resting Doppler echocardiographic findings and clinical symptoms or signs".
Screening
According to the 2014 and 2017 AHA/ACC Guideline, screening for mitral stenosis by TTE is recommended among patients with signs or symptoms. " Exercise testing with Doppler or invasive hemodynamic assessment is recommended to evaluate the response of the mean mitral gradient and pulmonary artery pressure in patients with MS when there is a discrepancy between resting Doppler echocardiographic findings and clinical symptoms or signs".